Genitourinary Cancers

Circulating Tumor Cell Count May Predict for Overall Survival in Prostate Cancer

Circulating Tumor Cell Count May Predict for Overall Survival in Prostate Cancer

By

Researchers assessed CTC and PSA response endpoints in 6081 patients enrolled in 1 of 5 randomized phase 3 studies.

Apalutamide Granted Priority Review for Castration-resistant Prostate Cancer

Apalutamide Granted Priority Review for Castration-resistant Prostate Cancer

By

Apalutamide is a next-generation, orally administered inhibitor of the androgen receptor.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs